交易 Faron Pharmaceuticals Oy - FARN 差價合約

交易條件

• 類型: 差價合約
• 點差: 0.0210
• 長倉隔夜倉息調整: -0.02127%
• 短倉隔夜倉息調整: -0.00065%
• 隔夜倉息調整時間: 21:00 (UTC)
• 貨幣: GBP
• 最低成交量: 10
• 保證金: 20.00%
• 證券交易所: United Kingdom of Great Britain and Northern Ireland
• 交易佣金: 0%
• 保證止損溢價: 1%

主要統計數據

• 前收盤價: 0.4595
• 開倉: 0.4395
• 1 年變化: -18.46%
• 日區間: 0.4395 - 0.4495

Faron Pharmaceuticals Oy (LSE: FARN) is a clinical-stage biopharmaceutical company based in Finland, focused on immunotherapies for cancer and acute inflammatory conditions. Its lead candidate, bexmarilimab, is being developed to enhance immune response in solid tumours and sepsis. Faron leverages scientific innovation and clinical partnerships to advance novel treatments for serious diseases.